Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| 1 |
Starbucks
SBUX
|
+$382M |
| 2 |
CELG
Celgene Corp
CELG
|
+$329M |
| 3 |
Tesla
TSLA
|
+$261M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$254M |
| 5 |
Intel
INTC
|
+$246M |
Top Sells
| 1 |
Fortive
FTV
|
+$1.15B |
| 2 |
ANDV
Andeavor
ANDV
|
+$1.11B |
| 3 |
AET
Aetna Inc
AET
|
+$535M |
| 4 |
Microsoft
MSFT
|
+$331M |
| 5 |
Amazon
AMZN
|
+$262M |
Sector Composition
| 1 | Technology | 13.89% |
| 2 | Healthcare | 13.88% |
| 3 | Financials | 13.32% |
| 4 | Consumer Discretionary | 11.78% |
| 5 | Industrials | 10.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2601
i3 Verticals
IIIV
$724M
| $493K | ﹤0.01% |
20,475
-20,985
| -51% | -$505K |
|
2602
Brighthouse Financial
BHF
$2.8B
| $492K | ﹤0.01% |
16,146
-193,585
| -92% | -$5.9M |
|
2603
Anterix
ATEX
$395M
| $490K | ﹤0.01% |
13,104
-48,376
| -79% | -$1.81M |
|
2604
TG Therapeutics
TGTX
$5.1B
| $490K | ﹤0.01% |
119,611
-161,704
| -57% | -$662K |
|
2605
ANI Pharmaceuticals
ANIP
$2.12B
| $488K | ﹤0.01% |
10,831
-2,247
| -17% | -$101K |
|
2606
Digi International
DGII
$1.33B
| $488K | ﹤0.01% |
48,342
-5,591
| -10% | -$56.4K |
|
2607
AMC Networks
AMCX
$357M
| $487K | ﹤0.01% |
8,866
-200,639
| -96% | -$11M |
|
|
NLSN
2608
DELISTED
Nielsen Holdings plc
NLSN
| $487K | ﹤0.01% |
+20,853
| New | +$487K |
|
2609
Altisource Portfolio Solutions
ASPS
$123M
| $484K | ﹤0.01% |
+2,691
| New | +$484K |
|
2610
GrafTech
EAF
$261M
| $483K | ﹤0.01% |
4,223
-204,299
| -98% | -$23.4M |
|
2611
Appian
APPN
$2.28B
| $481K | ﹤0.01% |
+18,023
| New | +$481K |
|
|
NXGN
2612
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $480K | ﹤0.01% |
31,705
-45,691
| -59% | -$692K |
|
2613
First Financial Bancorp
FFBC
$2.46B
| $479K | ﹤0.01% |
20,190
-63,074
| -76% | -$1.5M |
|
2614
Bio-Techne
TECH
$7.97B
| $479K | ﹤0.01% |
13,248
-315,128
| -96% | -$11.4M |
|
2615
AudioEye
AEYE
$166M
| $476K | ﹤0.01% |
+55,642
| New | +$476K |
|
2616
DigitalBridge
DBRG
$2.2B
| $476K | ﹤0.01% |
25,446
-120,067
| -83% | -$2.25M |
|
2617
Orrstown Financial Services
ORRF
$687M
| $476K | ﹤0.01% |
26,115
+2,126
| +9% | +$38.8K |
|
|
MLNT
2618
DELISTED
Melinta Therapeutics, Inc. Common Stock
MLNT
| $476K | ﹤0.01% |
120,037
-30,830
| -20% | -$122K |
|
|
TPCO
2619
DELISTED
Tribune Publishing Company Common Stock
TPCO
| $475K | ﹤0.01% |
41,885
+16,514
| +65% | +$187K |
|
2620
ORIX
IX
$30B
| $472K | ﹤0.01% |
32,960
-11,940
| -27% | -$171K |
|
2621
Schwab Short-Term US Treasury ETF
SCHO
$11.1B
| $471K | ﹤0.01% |
+18,892
| New | +$471K |
|
2622
Riverview Bancorp
RVSB
$102M
| $470K | ﹤0.01% |
64,562
-42,614
| -40% | -$310K |
|
|
ARTX
2623
DELISTED
Arotech Corporation
ARTX
| $470K | ﹤0.01% |
179,416
-18,650
| -9% | -$48.9K |
|
2624
IES Holdings
IESC
$7.5B
| $467K | ﹤0.01% |
+30,027
| New | +$467K |
|
2625
CNB Financial Corp
CCNE
$761M
| $466K | ﹤0.01% |
20,313
+2,301
| +13% | +$52.8K |
|